Open AccessAspirin and Angiotensin-Converting Enzyme Inhibitors Among Elderly Survivors of Hospitalization for an Acute Myocardial Infarction
Author(s) -
Harlan M. Krumholz,
Ya-Ting Chen,
Yongfei Wang,
Martha J. Radford
Publication year - 2001
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.161.4.538
Subject(s) - aspirin , medicine , myocardial infarction , angiotensin converting enzyme , ace inhibitor , confidence interval , relative risk , randomized controlled trial , cardiology , blood pressure
Aspirin and angiotensin-converting enzyme (ACE) inhibitors are recommended for secondary prevention after acute myocardial infarction (AMI), but several studies have suggested that the combination of these medications may produce a negative interaction.